Wide occurrence of measles virus subgenomic RNAs in attenuated live-virus vaccines

Related Experiment Videos

C Bellocq1, G Mottet, L Roux

  • 1Department of Microbiology, University of Geneva Medical School, Switzerland.

Insights

Northern blot analysis revealed subgenomic RNAs in six of nine measles vaccine preparations. These RNAs, linked to specific viral strains, may impact vaccine attenuation and efficacy.

Area of Science:

  • Virology
  • Vaccinology
  • Molecular Biology

Background:

  • Measles vaccines are crucial for preventing measles virus infection.
  • The composition of live-virus vaccines, including measles vaccine preparations, can influence their performance.
  • Defective interfering particles (DIPs) are known to affect viral replication and attenuation.

Purpose of the Study:

  • To analyze the nucleocapsid RNA content of various measles vaccine preparations.
  • To investigate the presence and nature of subgenomic RNAs in measles vaccines.
  • To discuss the implications of subgenomic RNAs and DIPs for vaccine efficacy and safety.

Main Methods:

  • Analysis of nine measles vaccine preparations from eight manufacturers.
  • Utilized Northern blot technique to examine nucleocapsid RNA.
  • Correlated RNA findings with specific viral strains used in the vaccines.

Main Results:

  • Six out of nine measles vaccine preparations contained subgenomic RNAs alongside genomic RNA.
  • The presence or absence of subgenomic RNAs strictly correlated with the viral strains employed.
  • Identified potential defective interfering particles (DIPs) in the vaccine preparations.

Conclusions:

  • Subgenomic RNAs, potentially indicative of DIPs, are present in a majority of analyzed measles vaccines.
  • The viral strain is a key determinant for the presence of these subgenomic RNAs.
  • Further research is warranted to understand the role of DIPs in measles vaccine attenuation, efficacy, and safety.

Related Concept Videos